Cell-cycle dysregulation and anticancer therapy

Author： Stewart Z.A.   Westfall M.D.   Pietenpol J.A.  

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.24, Iss.3, 2003-03, pp. : 139-145

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cell Cycle Dysregulation During Hiv Infection: Perspectives of a Target Based Therapy

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 2, Iss. 1, 2002-04 ,pp. : 53-62

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging cell-cycle inhibitors for pancreatic cancer therapy

By Bayraktar Soley  

Expert Opinion on Emerging Drugs, Vol. 17, Iss. 4, 2012-12 ,pp. : 571-582

Informa Healthcare

Access to resources Recommend Favorite

A Mechanistic Approach to Anticancer Therapy: Targeting the Cell Cycle with Histone Deacetylase Inhibitors

By  

Current Pharmaceutical Design, Vol. 11, Iss. 9, 2005-01 ,pp. : 1091-1104

Bentham Science Publishers

Access to resources Recommend Favorite

Exploiting Novel Cell Cycle Targets in the Development of Anticancer Agents

By  

Current Cancer Drug Targets, Vol. 5, Iss. 2, 2005-03 ,pp. : 85-102

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular targets for cell cycle inhibition and cancer therapy

By Lee Mong-Hong   Yang Heng-Yin  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 3, 2003-03 ,pp. : 329-346

Informa Healthcare

Access to resources Recommend Favorite